Abstract |
Combined islet and kidney xenotransplantation for the treatment of diabetic nephropathy represents a compelling and increasingly relevant therapeutic possibility for an ever-growing number of patients who would benefit from both durable renal replacement and cure of the underlying cause of their renal insufficiency: diabetes. Here we briefly review immune barriers to islet transplantation, highlight preclinical progress in the field, and summarize our experience with combined islet and kidney xenotransplantation, including both challenges with islet-kidney composite grafts as well as our recent success with sequential kidney followed by islet xenotransplantation in a pig-to-baboon model.
|
Authors | Daniel L Eisenson, Hayato Iwase, Weili Chen, Yu Hisadome, Wanxing Cui, Michelle R Santillan, Alexander C Schulick, Du Gu, Amanda Maxwell, Kristy Koenig, Zhaoli Sun, Daniel Warren, Kazuhiko Yamada |
Journal | Frontiers in immunology
(Front Immunol)
Vol. 15
Pg. 1351717
( 2024)
ISSN: 1664-3224 [Electronic] Switzerland |
PMID | 38476227
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2024 Eisenson, Iwase, Chen, Hisadome, Cui, Santillan, Schulick, Gu, Maxwell, Koenig, Sun, Warren and Yamada. |
Topics |
- Humans
- Swine
- Animals
- Islets of Langerhans Transplantation
- Diabetic Nephropathies
- Transplantation, Heterologous
- Kidney
- Diabetes Mellitus, Type 1
|